Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Samuelsen, Ørjan ^a,b   Overballe Petersen, Søren ^b   Bjørnholt, Jørgen Vildershøj ^c,f,g   Brisse, Sylvain ^d   Doumith, Michel ^e   Woodford, Neil ^e   Hopkins, Katie L ^e   Aasnæs, Bettina ^a   Haldorsen, Bjørg ^a   Sundsfjord, Arnfinn ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d INSTITUT PASTEUR   (France)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f UNIVERSITY OF OSLO   (Norway)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COLISTIN; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MECILLINAM; MEROPENEM; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLAKPC GENE; BLANDM GENE; BLAOXA 48 LIKE GENE; BLAVIM GENE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; MULTIGENE FAMILY; NONHUMAN; NORWAY; PHENOTYPE; WHOLE GENOME SEQUENCING; BIOSYNTHESIS; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; EPIDEMIC; GENETICS; HISTORY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYLOGENY; RETROSPECTIVE STUDY; TRAVEL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HISTORY, 21ST CENTURY; HUMANS; MICROBIAL SENSITIVITY TESTS; NORWAY; PHYLOGENY; RETROSPECTIVE STUDIES; TRAVEL;

EID: 85034071680     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0187832     Document Type: Article

References (74)

1. Tangden T, Giske CG. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Int Med. 2015; 277(5):501–12.
2. Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae: a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015; 59(10):5873–84. https://doi.org/10.1128/AAC.01019-15 PMID: 26169401
3. Temkin E, Adler A, Lerner A, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci. 2014; 1323:22–42. https://doi.org/10.1111/nyas.1253 PMID: 25195939
4. Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RA. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy? Expert Opin Pharmacother. 2016; 17(6):761–81. https://doi.org/10.1517/14656566.2016.1145658 PMID: 26799840
5. Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015; 70(7):2133–43. https://doi.org/10.1093/jac/dkv086 PMID: 25900159
6. Doi Y, Paterson DL. Carbapenemase-producing Enterobacteriaceae. Semin Resp Crit Care Med. 2015; 36(1):74–84.
7. Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasevic AT, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017; 17(2):153–63. https://doi.org/10.1016/S1473-3099(16)30257-2 PMID: 27866944
8. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014; 19(42) pii: 20939.
9. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016; 16(2):161–8. https://doi.org/10.1016/S1473-3099(15)00424-7 PMID: 26603172
10. Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. 2016; 21 (27) https://doi.org/10.2807/1560-7917.ES.2016.21.27.30280 PMID: 27416987
11. Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S, et al. mcr-1.2, a new mcr variant carried on a transferable plasmid from a colistin-resistant KPC carbapenemase-producing Klebsiella pneumoniae strain of sequence type 512. Antimicrob Agents Chemother. 2016; 60(9):5612–5. https://doi.org/10.1128/AAC.01075-16 PMID: 27401575
12. Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z, et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. mBio. 2017; 8(3) pii: e00543-17.
13. Carattoli A, Villa L, Feudi C, Curcio L, Orsini S, Luppi A, et al. Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Euro Surveill. 2017; 22(31) pii: 30589.
14. Borowiak M, Fischer J, Hammerl JA, Hendriksen RS, Szabo I, Malorny B. Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob Chemother. 2017;Sep 18. doi: 10.1093/jac/dkx327. [Epub ahead of print]. PMID: 28962028
15. Falgenhauer L, Waezsada SE, Yao Y, Imirzalioglu C, Kasbohrer A, Roesler U, et al. Colistin resistance gene mcr-1 in extended-spectrum-β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect Dis. 2016; 16(3):282–3. https://doi.org/10.1016/S1473-3099(16)00009-8 PMID: 26774242
16. Mulvey MR, Mataseje LF, Robertson J, Nash JH, Boerlin P, Toye B, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016; 16(3):289–90. https://doi.org/10.1016/S1473-3099(16)00067-0 PMID: 26973304
17. Li A, Yang Y, Miao M, Chavda KD, Mediavilla JR, Xie X, et al. Complete sequences of mcr-1-harboring plasmids from extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacteriaceae. Antimicrob Agents and Chemother. 2016; 60(7):4351–4.
18. Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014; 20(9):821–30. https://doi.org/10.1111/1469-0691.12719 PMID: 24930781
19. Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL, European Survey of Carbapenemase-Producing Enterobacteriaceae working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015; 20(45) https://doi.org/10.2807/1560-7917.ES.2015.20.45.30062 PMID: 26675038
20. Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017; 215(suppl_1):S28–S36. https://doi.org/10.1093/infdis/jiw282 PMID: 28375512
21. Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015; 28(3):565–91. https://doi.org/10.1128/CMR.00116-14 PMID: 25926236
22. Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard AS, et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis. 2014; 20(11):1812–20. https://doi.org/10.3201/eid2011.140206 PMID: 25341126
23. Potron A, Poirel L, Rondinaud E, Nordmann P. Intercontinental spread of OXA-48 β-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill. 2013; 18(31) pii: 20549.
24. Poirel L, Bonnin RA, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother. 2012; 56(1):559–62. https://doi.org/10.1128/AAC.05289-11 PMID: 22083465
25. Carattoli A, Seiffert SN, Schwendener S, Perreten V, Endimiani A. Differentiation of IncL and IncM plasmids associated with the spread of clinically relevant antimicrobial resistance. PLoS ONE. 2015; 10(5): e0123063. https://doi.org/10.1371/journal.pone.0123063 PMID: 25933288
26. Lofmark S, Sjostrom K, Makitalo B, Edquist P, Tegmark Wisell K, Giske CG. Carbapenemase-producing Enterobacteriaceae in Sweden 2007–2013: Experiences from seven years of systematic surveillance and mandatory reporting. Drug Resist Updates. 2015; 20:29–38.
27. Osterblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008–11). J Antimicrob Chemother. 2012; 67(12):2860–4. https://doi.org/10.1093/jac/dks299 PMID: 22855858
28. Samuelsen Ø, Naseer U, Tofteland S, Skutlaberg DH, Onken A, Hjetland R, et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother. 2009; 63(4):654–8. https://doi.org/10.1093/jac/dkp018 PMID: 19218573
29. Samuelsen Ø, Naseer U, Karah N, Lindemann PC, Kanestrom A, Leegaard TM, et al. Identification of Enterobacteriaceae isolates with OXA-48 and coproduction of OXA-181 and NDM-1 in Norway. J Antimicrob Chemother. 2013; 68(7):1682–5. https://doi.org/10.1093/jac/dkt058 PMID: 23463214
30. Samuelsen Ø, Thilesen CM, Heggelund L, Vada AN, Kummel A, Sundsfjord A. Identification of NDM-1producing Enterobacteriaceae in Norway. J Antimicrob Chemother. 2011; 66(3):670–2. https://doi.org/10.1093/jac/dkq483 PMID: 21172785
31. Samuelsen Ø, Toleman MA, Hasseltvedt V, Fuursted K, Leegaard TM, Walsh TR, et al. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect. 2011; 17(12):1811–6. https://doi.org/10.1111/j.1469-0691.2011.03532.x PMID: 21595797
32. Hammerum AM, Littauer P, Hansen F. Detection of Klebsiella pneumoniae co-producing NDM-7 and OXA-181, Escherichia coli producing NDM-5 and Acinetobacter baumannii producing OXA-23 in a single patient. Int J Antimicrob Agents. 2015; 46(5):597–8. https://doi.org/10.1016/j.ijantimicag.2015.07.008 PMID: 26307465
33. Jakobsen L, Hammerum AM, Hansen F, Fuglsang-Damgaard D. An ST405 NDM-4-producing Escherichia coli isolated from a Danish patient previously hospitalized in Vietnam. J Antimicrob Chemother. 2014; 69(2):559–60. https://doi.org/10.1093/jac/dkt356 PMID: 24013194
34. Hammerum AM, Larsen AR, Hansen F, Justesen US, Friis-Moller A, Lemming LE, et al. Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus. Int J Antimicrobial Agents. 2012; 40(2):191–2.
35. Nielsen JB, Hansen F, Littauer P, Schonning K, Hammerum AM. An NDM-1-producing Escherichia coli obtained in Denmark has a genetic profile similar to an NDM-1-producing E. coli isolate from the UK. J Antimicrob Chemother. 2012; 67(8):2049–51. https://doi.org/10.1093/jac/dks149 PMID: 22532468
36. Hammerum AM, Toleman MA, Hansen F, Kristensen B, Lester CH, Walsh TR, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010; 10(12):829–30. https://doi.org/10.1016/ S1473-3099(10)70276-0 PMID: 21109169
37. Wang M, Ellermann-Eriksen S, Hansen DS, Kjerulf A, Fuglsang-Damgaard D, Holm A, et al. Epidemic increase in the incidence of carbapenemase-producing Enterobacteriaceae in Denmark. Ugeskr Laeger. 2016; 178(45) pii: V06160422.
38. NDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca. J Antimicrob Chemother. 2016; 71(11):3117–24. https://doi.org/10.1093/jac/dkw289 PMID: 27494919
39. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012; 18(9):1503–7. https://doi.org/10.3201/eid1809.120355 PMID: 22932472
40. Dortet L, Brechard L, Poirel L, Nordmann P. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J Med Microbiol. 2014; 63(Pt 5):772–6. https://doi.org/10.1099/jmm.0.071340-0 PMID: 24591705
41. KPC gene. Antimicrob Agents Chemother. 2008; 52(4):1257–63. https://doi.org/10.1128/AAC.01451-07 PMID: 18227185
42. Mendes RE, Kiyota KA, Monteiro J, Castanheira M, Andrade SS, Gales AC, et al. Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol. 2007; 45(2):544–7. https://doi.org/10.1128/JCM.01728-06 PMID: 17093019
43. Swayne RL, Ludlam HA, Shet VG, Woodford N, Curran MD. Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents. 2011; 38(1):35–8. https://doi.org/10.1016/j.ijantimicag.2011.03.010 PMID: 21549572
44. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diag Microbiol Infect Dis. 2011; 70(1):119–23.
45. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012; 19(5):455–77. https://doi.org/10.1089/cmb.2012.0021 PMID: 22506599
46. Koren S, Treangen TJ, Hill CM, Pop M, Phillippy AM. Automated ensemble assembly and validation of microbial genomes. BMC Bioinformatics. 2014; 15:126. https://doi.org/10.1186/1471-2105-15-126 PMID: 24884846
47. Treangen TJ, Ondov BD, Koren S, Phillippy AM. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 2014; 15(11):524. https://doi.org/10.1186/s13059-014-0524-x PMID: 25410596
48. Doumith M, Day M, Ciesielczuk H, Hope R, Underwood A, Reynolds R, et al. Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol. 2015; 53(1):160–6. https://doi.org/10.1128/JCM.02562-14 PMID: 25355761
49. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014; 30(9):1312–3. https://doi.org/10.1093/bioinformatics/btu033 PMID: 24451623
50. Tofteland S, Naseer U, Lislevand JH, Sundsfjord A, Samuelsen Ø. A long-term low-frequency hospital outbreak of KPC-producing Klebsiella pneumoniae involving Intergenus plasmid diffusion and a persisting environmental reservoir. PLoS ONE. 2013; 8(3):e59015. https://doi.org/10.1371/journal.pone.0059015 PMID: 23536849
51. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3):268–81. https://doi.org/10.1111/j.1469-0691.2011.03570.x PMID: 21793988
52. Leclercq R, Canton R, Brown DF, Giske CG, Heisig P, MacGowan AP, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013; 19(2):141–60. https://doi.org/10.1111/j.1469-0691.2011.03703.x PMID: 22117544
53. Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014; 5:643. https://doi.org/10.3389/fmicb.2014.00643 PMID: 25505462
54. Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK, et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents. 2014; 44(6):500–7. https://doi.org/10.1016/j.ijantimicag.2014.07.020 PMID: 25264127
55. Dortet L, Cuzon G, Nordmann P. Dissemination of carbapenemase-producing Enterobacteriaceae in France, 2012. J Antimicrob Chemother. 2014; 69(3):623–7. https://doi.org/10.1093/jac/dkt433 PMID: 24275115
56. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011; 35(5):736–55. https://doi.org/10.1111/j.1574-6976.2011.00268.x PMID: 21303394
57. VIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary. J Antimicrob Chemother. 2010; 65(6):1303–5. https://doi.org/10.1093/jac/dkq133 PMID: 20410063
58. Oteo J, Perez-Vazquez M, Bautista V, Ortega A, Zamarron P, Saez D, et al. The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3. J Antimicrob Chemother. 2016.
59. Maatallah M, Vading M, Kabir MH, Bakhrouf A, Kalin M, Naucler P, et al. Klebsiella variicola is a frequent cause of bloodstream infection in the stockholm area, and associated with higher mortality compared to K. pneumoniae. PLoS ONE. 2014; 9(11):e113539. https://doi.org/10.1371/journal.pone.0113539 PMID: 25426853
60. Chen YT, Lin JC, Fung CP, Lu PL, Chuang YC, Wu TL, et al. KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. J Antimicrob Chemother. 2014; 69(3):628–31. https://doi.org/10.1093/jac/dkt409 PMID: 24123430
61. Toleman MA, Bugert JJ, Nizam SA. Extensively drug-resistant New Delhi metallo-β-lactamase-encoding bacteria in the environment, Dhaka, Bangladesh, 2012. Emerg Infect Dis. 2015; 21(6):1027–30. https://doi.org/10.3201/eid2106.141578 PMID: 25989320
62. Pannaraj PS, Bard JD, Cerini C, Weissman SJ. Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States. Pediatr Infect Dis J. 2015; 34 (1):11–6. https://doi.org/10.1097/INF.0000000000000471 PMID: 25093977
63. Peirano G, Ahmed-Bentley J, Fuller J, Rubin JE, Pitout JD. Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years. J Clin Microbiol. 2014; 52(5):1575–81. https://doi.org/10.1128/JCM.00162-14 PMID: 24599977
64. Mataseje LF, Abdesselam K, Vachon J, Mitchel R, Bryce E, Roscoe D, et al. Carbapenem-producing Enterobacteriaceae in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 2010–2014. Antimicrob Agents Chemother. 2016; 60(11):6787–94. https://doi.org/10.1128/AAC.01359-16 PMID: 27600052
65. Poirel L, Savov E, Nazli A, Trifonova A, Todorova I, Gergova I, et al. Outbreak caused by NDM-1- and RmtB-producing Escherichia coli in Bulgaria. Antimicrob Agents Chemother. 2014; 58(4):2472–4. https://doi.org/10.1128/AAC.02571-13 PMID: 24514099
66. Wachino J, Arakawa Y. Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update. Drug Resist Updates. 2012; 15(3):133–48.
67. Marrs EC, Day KM, Perry JD. In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase. J Antimicrob Chemother. 2014; 69(10):2873–5. https://doi.org/10.1093/jac/dku204 PMID: 24917584
68. Giske CG. Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin. Clin Microbiol Infect. 2015; 21(10):899–905. https://doi.org/10.1016/j.cmi.2015.05.022 PMID: 26027916
69. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemotherapy. 2013; 57(9):4578–80.
70. Osterblad M, Hakanen AJ, Jalava J. Evaluation of the Carba NP test for carbapenemase detection. Antimicrob Agents Chemother. 2014; 58(12):7553–6. https://doi.org/10.1128/AAC.02761-13 PMID: 25246404
71. Oueslati S, Nordmann P, Poirel L. Heterogeneous hydrolytic features for OXA-48-like β-lactamases. J Antimicrob Chemother. 2015; 70(4):1059–63. https://doi.org/10.1093/jac/dku524 PMID: 25583748
72. Literacka E, Herda M, Baraniak A, Zabicka D, Hryniewicz W, Skoczynska A, et al. Evaluation of the Carba NP test for carbapenemase detection in Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., and its practical use in the routine work of a national reference laboratory for susceptibility testing. Eur J Clin Microbiol Infect Dis. 2017; 36(11):2281–87. https://doi.org/10.1007/s10096-017-3062-0 PMID: 28744664
73. Huang TD, Poirel L, Bogaerts P, Berhin C, Nordmann P, Glupczynski Y. Temocillin and piperacillin/ tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J Antimicrob Chemother. 2014; 69(2):445–50. https://doi.org/10.1093/jac/dkt367 PMID: 24055766
74. NORM/NORM-VET. NORM/NORM-VET 2015. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo: 2016.